Nuvectis Pharma (NASDAQ:NVCT – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.04, FiscalAI reports. Here are the key takeaways from Nuvectis Pharma’s conference call: NXP100 has moved into commercial-stage development in China: Ciprocopan was approved […]

USANA Health Sciences (NYSE:USNA – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.22), FiscalAI reports. The firm had revenue of $205.89 million during the quarter, compared to analysts’ expectations of $217.42 million. USANA Health Sciences […]

Universal Health Services (NYSE:UHS – Get Free Report) announced its quarterly earnings data on Tuesday. The health services provider reported $5.22 EPS for the quarter, beating analysts’ consensus estimates of $5.19 by $0.03, Zacks reports. Universal Health Services had a return on equity of 19.39% and a net margin of 8.42%. Universal Health Services Stock […]